However, while the ratio of AML versus T-cell lymphoma was not altered, the incidence of mature CD4+ T-cell lymphoma increased at the expense of immature CD4+/CD8+ T-cell lymphoma in MYC/FLIPL mice. This evidence concerns the gene CD8A and T-cell non-Hodgkin lymphoma.